 Medscape |
Management of Rheumatologic Diseases in Pregnancy
Medscape Chakravarty EF, Murray ER, Kelman A, Farmer P. Pregnancy outcomes after maternal exposure to rituximab. Blood117,1499–1506 (2011). Fischer-Betz R, Specker C, Schneider M. Successful outcome of two pregnancies in patients with adult-onset Still’s … |
Which Abbott Is the One to Own Post-Split?Investorplace.comBut AbbVie has a very robust pipeline, including Daclizumab (with Phase III results due in 2014), chronic kidney disease drug bardoxolone (in Phase III) and elotuzumab for multiple myeloma (in …
Breakthrough in treatment of blood cancer patientsDaily EchoThe trial, of which part was carried out at the University of Southampton, revealed that the injection of the drug, rituximab, worked just as effectively as the tradition treatment. Dr Andrew …
|
Analyst: Biogen Idec Gains Are Done
24/7 Wall St. Pipeline: daclizumab, anti-LINGO, others could create long-term value. While we expect weakness on BG-12 launch, we think BIIB’s pipeline will create significant long-term value. For investors with a 12-month+ horizon, we think BG-12-driven weakness … |
|
CTI announces preclinical study of Pixuvri, provides mechanism for lower …
pharmabiz.com The EMA Committee for Medicinal Products for Human Use has accepted PIX306, CTI’s ongoing randomized controlled phase III clinical trial, which compares Pixuvri-rituximab to gemcitabine-rituximab in patients who have relapsed after one to three prior … |
|
Preclinical Study Provides Potential Mechanisms for Lower Cardiotoxicity in …
PharmaLive (press release) (subscription) The European Medicines Agency’s (the “EMA”) Committee for Medicinal Products for Human Use has accepted PIX306, CTI’s ongoing randomized controlled phase III clinical trial, which compares Pixuvri-rituximab to gemcitabine-rituximab in patients who … |
|
Crunching the Abbott Spinoff Numbers (ABT, ABBV) : Small Cap Diligence
SmallCap Network Daclizumab, bardoxolone (chronic kidney disease), and elotuzumab (multiple myeloma) are all in Phase III trials, with about ten more solid developments in Phase II testing. As for Abbott Laboratories, the device and equipment manufacturer, it’s also a … |
Cambridge NewsHow Zoe will spend her Christmas in isolationCambridge NewsHowever, when medics could not find a donor, she was treated in isolation with horse antibodies called anti thymocyte globulin (ATG). This treatment is a second resort as it is no…
Norwegian Newspaper, News Site, Feature ME/CFS Patient Improved by …ProHealthOn Dec 13, the Norwegian newspaper Aftenposten posted a video on its site featuring an interview (in Norwegian) with Maria Gjerpe, one of the ME/CFS patients who improved si…
Anti-thymocyte globulin (ATG) differentially depletes naive and memory T cells …7thSpace Interactive (press release)Anti-thymocyte globulin (ATG) differentially depletes naive and memory T cells and permits memory-type regulatory T cells in nonobese …